Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?

International Journal of Radiation Oncology, Biology, Physics

Volumn 33, Issue 3, 1995, Pages 663-673

  O'Neill, Brian P ^a   O'Fallon, Judith R ^a   Earle, John D ^a   Colgan, Joseph P ^a   Brown, Loren D ^b   Krigel, Robert L ^b  

^a MAYO CLINIC   (United States)

^b North Central Cancer Treatment Group Rochester   (United States)

Author keywords

Combined initial therapy; PCNSL

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; PREDNISONE; PYRIDOXINE; VINCRISTINE;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; MALE; NAUSEA; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN INFLAMMATION; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREDNISOLONE; VINCRISTINE;

EID: 0028817810     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)00207-F     Document Type: Article

References (50)

1. Sequential combination of systemic high-dose ara-C and asparaginase for the treatment of central nervous system leukemia and lymphoma
2. Radiation therapy in the management of primary malignant lymphoma of the brain
3. Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone
4. Neurological complications of malignant lymphoma
5. Primary central nervous system lymphoma: A role for adjuvant chemotherapy
6. Central nervous system pharmacokinetics of high-dose cytosine arabinoside
7. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy
8. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma
9. Effect of age on therapeutic outcome in advanced diffuse histocytic lymphoma: The Southwest Oncology Group experience
10. Increasing incidence of primary brain lymphoma in the US
11. Meningeal involvement in non-Hodgkin's lymphoma: Symptoms, incidence, risk factors and treatment
12. Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate
13. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
14. Occurrence and prognosis of extranodal lymphomas
15. Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma
16. High-dose methotrexate for non-AIDS primary central nervous system lymphoma: Report of 13 cases
17. Primary central nervous system lymphoma in homosexual men: Clinical, immunologic and pathologic features
18. CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavorable histopathology: A randomized clinical trial
19. Primary malignant lymphomas of the central nervous system
20. Primary lymphoma of the central nervous system: Manitoba experience and literature review
21. Neurophysiologic impairment in astrocytoma survivors
22. Primary central nervous system lymphoma
23. CNS involvement in the non-Hodgkin's lymphomas
24. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature
25. Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases
26. Involvement of the central nervous system by non-Hodgkin's lymphoma in adults: A review of 36 cases
27. Primary lymphoma of the central nervous system: Computerized tomography scan characteristics and treatment results for 12 cases
28. Primary malignant lymphoma of the central nervous system: Results of treatment of 11 cases and review of the literature
29. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315
30. Developments in the diagnosis and treatment of primary CNS lymphoma
31. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function
32. Primary central nervous system lymphoma
33. Computer-assisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma
34. Measurements of blood-brain barrier permeability in patients underoing radiotherapy and chemotherapy for primary cerebral lymphoma
35. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature
36. MR of primary CNS lymphoma in immunologically normal patients
37. Spontaneous temporary remission in primary CNS lymphoma
38. The reticulum cell sarcoma—Microglioma group of brain tumors
39. Primary lymphomas of the brain: A clinco-pathologic review of 37 cases
40. Primary intracranial CNS lymphoma: MR manifestations
41. Therapy of adult malignant brain tumors: What have the clinical trials taught us?
42. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy
43. Sites of origin of primary intracerebral malignant lymphoma
44. Steroid-induced remissions in CNS lymphoma
45. Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome (letter to the editor)
46. Primary lymphoma of the central nervous system: An unresolved therapeutic problem
47. Age is the main prognostic factor in adult aggressive non-Hodgkin's lymphoma
48. Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of the brain: A case report
49. Combined modality treatment with primary CHOP chemotherapy followed by loco-regional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas
50. Primary cereberal lymphoma: The “ghost tumor”